GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Tianjin Chase Sun Pharmaceutical Co 300026.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

3.18

-1.24%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2024

Revenue

CN¥5.78bn

FY2015FY2024

Net income

CN¥21.5m

FY2015FY2024

Free cash flow

CN¥659.1m

FY2015FY2024

Shareholders' equity

CN¥8.64bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueCN¥5.78bnCN¥6.11bnCN¥6.65bnCN¥7.67bnCN¥6.49bnCN¥5.00bnCN¥4.22bnCN¥3.37bnCN¥3.87bnCN¥3.35bn
Research and developmentCN¥228.5mCN¥215.6mCN¥236.7mCN¥203.4mCN¥180.2mCN¥182.5mCN¥142.0mCN¥109.2mCN¥123.7mCN¥90.4m
Operating incomeCN¥66.7mCN¥537.4mCN¥783.7mCN¥875.2mCN¥684.1mCN¥499.7mCN¥291.6mCN¥592.3mCN¥737.7mCN¥579.2m
Net incomeCN¥21.5mCN¥506.6mCN¥624.2mCN¥687.3mCN¥573.4mCN¥402.5mCN¥210.8mCN¥450.7mCN¥658.5mCN¥534.9m
Diluted earnings per share0.010.170.200.240.190.170.080.150.220.19

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsCN¥11.17bnCN¥11.84bnCN¥12.63bnCN¥11.61bnCN¥10.18bnCN¥8.43bnCN¥7.48bnCN¥7.43bnCN¥7.28bnCN¥6.47bn
Cash and short-term investmentsCN¥1.31bnCN¥1.57bnCN¥1.21bnCN¥1.32bnCN¥1.13bnCN¥988.0mCN¥1.21bnCN¥1.35bnCN¥1.37bnCN¥1.39bn
Total liabilitiesCN¥2.37bnCN¥2.97bnCN¥4.17bnCN¥3.65bnCN¥2.79bnCN¥1.36bnCN¥907.6mCN¥919.6mCN¥1.24bnCN¥1.18bn
DebtCN¥656.6mCN¥1.34bnCN¥2.09bnCN¥1.96bnCN¥1.16bnCN¥369.8mCN¥216.0mCN¥270.4mCN¥496.6mCN¥316.6m
Shareholders' equityCN¥8.64bnCN¥8.71bnCN¥8.29bnCN¥7.77bnCN¥7.19bnCN¥6.79bnCN¥6.41bnCN¥6.35bnCN¥5.93bnCN¥5.27bn
Shares outstanding2,582m2,935m3,070m2,852m3,085m2,390m2,781m3,001m3,045m2,819m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsCN¥852.2mCN¥1.53bnCN¥745.3mCN¥391.6mCN¥196.7mCN¥216.1mCN¥388.2mCN¥742.4mCN¥448.1mCN¥121.0m
Capital spending−CN¥193.1m−CN¥347.1m−CN¥770.3m−CN¥677.5m−CN¥563.8m−CN¥591.0m−CN¥294.9m−CN¥383.3m−CN¥415.5m−CN¥223.4m
Free cash flowCN¥659.1mCN¥1.18bn−CN¥24.9m−CN¥285.9m−CN¥367.1m−CN¥374.9mCN¥93.3mCN¥359.0mCN¥32.6m−CN¥102.4m
Dividends paid−CN¥137.1m−CN¥154.7m−CN¥120.2m−CN¥120.2m−CN¥150.3m−CN¥59.5m−CN¥70.9m−CN¥94.3m−CN¥72.9m−CN¥70.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
RevenueCN¥1.06bnCN¥1.13bnCN¥1.35bnCN¥1.40bnCN¥1.39bnCN¥1.34bnCN¥1.44bnCN¥1.53bn
Operating incomeCN¥52.4mCN¥108.3mCN¥57.1mCN¥31.9mCN¥78.3m−CN¥165.7mCN¥36.8mCN¥98.8m
Net incomeCN¥12.4mCN¥65.7mCN¥2.1mCN¥18.3mCN¥60.3m−CN¥146.9mCN¥20.1mCN¥90.1m
Diluted earnings per share0.000.020.000.010.02-0.060.010.03
Cash from operations——CN¥153.0mCN¥279.0mCN¥103.0m—CN¥150.0mCN¥217.0m
Capital spending−CN¥19.0m−CN¥28.0m−CN¥21.0m−CN¥30.0m−CN¥44.0m−CN¥82.0m−CN¥30.0m−CN¥31.0m
Free cash flow——CN¥132.0mCN¥249.0mCN¥59.0m—CN¥120.0mCN¥186.0m
Total assetsCN¥10.33bnCN¥10.37bnCN¥10.76bnCN¥10.90bnCN¥11.03bnCN¥11.17bnCN¥11.37bnCN¥12.02bn
Cash and short-term investments——CN¥1.41bnCN¥1.33bnCN¥1.19bnCN¥1.31bnCN¥1.12bnCN¥1.65bn
DebtCN¥143.5mCN¥239.4mCN¥189.2mCN¥404.8mCN¥462.1mCN¥545.4mCN¥550.0mCN¥1.21bn
Shareholders' equityCN¥8.56bnCN¥8.58bnCN¥8.64bnCN¥8.64bnCN¥8.70bnCN¥8.64bnCN¥8.79bnCN¥8.77bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-9.0%2.9%7.3%
Operating income-57.6%-33.2%-18.1%
Net income-68.5%-44.4%-26.2%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin5.1%8.6%9.1%11.1%
Net margin4.4%7.0%7.5%9.2%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings455.824.627.932.524.620.840.228.425.137.1
Price to sales1.72.02.62.92.21.72.03.84.35.9

Dividends and splits

Per share, in the currency the company pays

Paid for 16 years. Last went ex-dividend on 15 Jul 2026.

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Paid in the year0.030.030.030.040.040.050.020.02
  • 3-for-1 split · 26 Oct 2016
  • 3-for-2 split · 26 May 2015
  • 3-for-2 split · 19 May 2014
  • 3-for-2 split · 7 May 2013
  • 3-for-2 split · 10 May 2012
  • 3-for-2 split · 19 May 2011

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.